Literature DB >> 27625328

Some prostate cancers are invisible to magnetic resonance imaging!

Leonard S Marks1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27625328     DOI： 10.1111/bju.13440

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  5 in total

Review 1.  Future Perspectives and Challenges of Prostate MR Imaging.

Authors:  Baris Turkbey; Peter L Choyke
Journal:  Radiol Clin North Am       Date:  2017-12-09       Impact factor: 2.303

Review 2.  Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy.

Authors:  Martin J Connor; Saiful Miah; Rajiv Jayadevan; Christopher C Khoo; David Eldred-Evans; Taimur Shah; Hashim U Ahmed; Leonard Marks
Journal:  Transl Androl Urol       Date:  2020-06

3.  Identifying Risk Factors for MRI-Invisible Prostate Cancer in Patients Undergoing Transperineal Saturation Biopsy.

Authors:  Alberto Artiles Medina; Rafael Rodríguez-Patrón Rodríguez; Mercedes Ruiz Hernández; Marina Mata Alcaraz; Silvia García Barreras; Guillermo Fernández Conejo; Agustín Fraile Poblador; Enrique Sanz Mayayo; Francisco Javier Burgos Revilla
Journal:  Res Rep Urol       Date:  2021-09-27

Review 4.  Targeted Prostate Biopsy in the Era of Active Surveillance.

Authors:  Fuad F Elkhoury; Demetrios N Simopoulos; Leonard S Marks
Journal:  Urology       Date:  2017-09-27       Impact factor: 2.633

5.  T1 and T2 MR fingerprinting measurements of prostate cancer and prostatitis correlate with deep learning-derived estimates of epithelium, lumen, and stromal composition on corresponding whole mount histopathology.

Authors:  Rakesh Shiradkar; Ananya Panda; Patrick Leo; Andrew Janowczyk; Xavier Farre; Nafiseh Janaki; Lin Li; Shivani Pahwa; Amr Mahran; Christina Buzzy; Pingfu Fu; Robin Elliott; Gregory MacLennan; Lee Ponsky; Vikas Gulani; Anant Madabhushi
Journal:  Eur Radiol       Date:  2020-09-02       Impact factor: 5.315
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.